Paper36980565
Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.
Kitsel Y and 3 others. Cancers (Basel), 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies. Papers, record 36980565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980565
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH |
Source NIH RePORTER
References189
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25942399 | BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection. | Br J Cancer | 2015 | https://conductscience.org/library/papers/25942399 | PubMed |
| 2 | 21514841 | CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. | J Vasc Interv Radiol | 2011 | https://conductscience.org/library/papers/21514841 | PubMed |
| 3 | 27907852 | The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. | Eur J Cancer | 2017 | https://conductscience.org/library/papers/27907852 | PubMed |
| 4 | 21900593 | Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. | Sci Transl Med | 2011 | https://conductscience.org/library/papers/21900593 | PubMed |
| 5 | 35246503 | Colorectal liver metastasis: molecular mechanism and interventional therapy. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35246503 | PubMed |
| 6 | 31056702 | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. | Ann Oncol | 2019 | https://conductscience.org/library/papers/31056702 | PubMed |
| 7 | 36262749 | Study of KRAS-Related miRNA Expression in Colorectal Cancer. | Cancer Manag Res | 2022 | https://conductscience.org/library/papers/36262749 | PubMed |
| 8 | 18676755 | K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18676755 | PubMed |
| 9 | 20567019 | Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20567019 | PubMed |
| 10 | 18757341 | Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18757341 | PubMed |
| 11 | 28632865 | Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. | JAMA | 2017 | https://conductscience.org/library/papers/28632865 | PubMed |
| 12 | 36268887 | The Role of 18F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors. | Mol Imaging Radionucl Ther | 2022 | https://conductscience.org/library/papers/36268887 | PubMed |
| 13 | 32779054 | Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases. | Ann Surg Oncol | 2020 | https://conductscience.org/library/papers/32779054 | PubMed |
| 14 | 29728604 | Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. | Nat Commun | 2018 | https://conductscience.org/library/papers/29728604 | PubMed |
| 15 | 27384594 | Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. | AJR Am J Roentgenol | 2016 | https://conductscience.org/library/papers/27384594 | PubMed |
| 16 | 19571295 | BRAF mutation in metastatic colorectal cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19571295 | PubMed |
| 17 | 22586653 | A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. | Cancer Discov | 2011 | https://conductscience.org/library/papers/22586653 | PubMed |
| 18 | 35780916 | Prognostic and predictive molecular biomarkers in advanced colorectal cancer. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35780916 | PubMed |
| 19 | 27334313 | RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. | J Gastrointest Surg | 2017 | https://conductscience.org/library/papers/27334313 | PubMed |
| 20 | 33005411 | Prognostic and predictive value of circulating DNA for hepatic arterial infusion of chemotherapy for patients with colorectal cancer liver metastases. | Mol Clin Oncol | 2020 | https://conductscience.org/library/papers/33005411 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42367489 | Metabolic and Inflammatory Markers of Fatty Liver As Associated Factors of Hepatic Metastatic Spread in Colorectal Cancer. | Cureus | 2026 | https://conductscience.org/library/papers/42367489 | PubMed |
| 41809353 | Prognostic value of primary tumor site in surgery for colorectal liver metastases. | World J Gastrointest Surg | 2026 | https://conductscience.org/library/papers/41809353 | PubMed |
| 41113971 | Prediction of pediatric Wilms tumor recurrence using interpretable machine learning models: insights from a 20-year real-world study and the prognostic value of Ki-67. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/41113971 | PubMed |
| 41007745 | Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007745 | PubMed |
| 40653800 | Utilizing intratumoral and peritumoral ultrasound radiomics for predicting KRAS gene mutation status in rectal cancer patients. | J Appl Clin Med Phys | 2025 | https://conductscience.org/library/papers/40653800 | PubMed |
| 40303874 | Liver Transplantation for Non-hepatocellular Carcinoma: The Role of Immune Checkpoint Inhibitors. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40303874 | PubMed |
| 39690384 | Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/39690384 | PubMed |
| 39183242 | Clinical value of sequential circulating tumor DNA analysis using next-generation sequencing and epigenetic modifications for guiding thermal ablation for colorectal cancer metastases: a prospective study. | Radiol Med | 2024 | https://conductscience.org/library/papers/39183242 | PubMed |
| 39172317 | Patterns and Predictors of Recurrence After Curative Resection of Colorectal Liver Metastasis (CRLM). | J Gastrointest Cancer | 2024 | https://conductscience.org/library/papers/39172317 | PubMed |
| 38239646 | Nomogram for predicting occurrence and prognosis of liver metastasis in elderly colorectal cancer patients: a population-based study. | Front Oncol | 2023 | https://conductscience.org/library/papers/38239646 | PubMed |
| 38089653 | 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained? | ACS Mater Au | 2023 | https://conductscience.org/library/papers/38089653 | PubMed |
| 37240247 | Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240247 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980565
GET https://conductscience.org/api/papers/v1/36980565/references?page=2